Psoriasis Therapeutics Pipeline to Witness Many Collaborations in the Coming Years: P&S Market Research

NEW YORK, April 02, 2018 -- According to a new research report titled “Psoriasis Therapeutics Pipeline Analysis 2017” published by P&S Market Research, Psoriasis currently exhibits a strong pipeline with 150 drug candidates.

Request for Sample Copy of this Research Report: https://www.psmarketresearch.com/market-analysis/psoriasis-therapeutic-pipeline-analysis/report-sample

The study analyzed that the psoriasis therapeutics pipeline comprises approximately 150 drug candidates in different stages of development. Psoriasis is a chronic inflammatory disorder that causes red patches covered with white scales on the skin. It is characterized when a person’s immune system sends defective signals which results in skin cells to grow rapidly. The body does not shed these excess skin cells and pile up on the surface of the skin, causing patches of psoriasis to appear. There are five types of psoriasis namely, plaque psoriasis or psoriasis vulgaris, guttate psoriasis, inverse psoriasis or flexural psoriasis or intertriginous psoriasis, pustular psoriasis, and erythrodermic or exfoliative psoriasis.

MC2 Therapeutics A/S is using PAD technology platform for the development of MC2-01 for the treatment of psoriasis. PAD technology platform offers a number of unique advantages in the development of new topical drugs. PAD vehicles are special made oil-in-water dispersions in which the internal oil phase is stabilized by encapsulation in a thin yet robust aqueous film of surfactants.

Browse Full Report with detailed TOC on “Psoriasis Therapeutics Pipeline Analysis” at: https://www.psmarketresearch.com/market-analysis/psoriasis-therapeutic-pipeline-analysis

Boehringer Ingelheim GmbH and AbbVie, Inc. entered in a worldwide agreement to develop and commercialize BI 655066, for the treatment of psoriasis.

Some of the key players developing drugs for the treatment of psoriasis include Amgen Inc., Maruho Co., Ltd., Boehringer Ingelheim GmbH and others.

More Reports Published by P&S Market Research

Systemic Lupus Erythematosus Pipeline Analysis - https://www.psmarketresearch.com/market-analysis/systemic-lupus-erythematosus-pipeline-analysis

Amyotrophic Lateral Sclerosis Pipeline Analysis - https://www.psmarketresearch.com/market-analysis/amyotrophic-lateral-sclerosis-pipeline-analysis

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: [email protected]

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook